Position in CLDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$561,385
+$118,100 QoQ
Shares Held
15,087
+8.0% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#144
of 252 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,205,847 across 455 Biotechnology names. CLDX ranks #149 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in CLDX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $561,385 | 15,087 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $443,285 | 13,975 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,534,532 | 240,594 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,333,622 | 244,825 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $5,346,451 | 262,725 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $2,115,672 | 116,566 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $3,611,435 | 142,914 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $4,431,649 | 130,381 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $2,004,979 | 54,174 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $2,799,986 | 66,714 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $5,786,155 | 145,894 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $3,948,101 | 143,463 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $5,840,505 | 172,134 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $3,922,683 | 109,024 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $5,191,111 | 116,471 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $4,064,339 | 144,587 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $2,617,465 | 97,087 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $7,040,200 | 206,700 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,407,743 | 139,952 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,147,074 | 39,768 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $729,826 | 21,825 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,139,158 | 55,299 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $8,760 | 500 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $12,842 | 866 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $26 | 2 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||